About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 290878, 9 pages
http://dx.doi.org/10.1155/2014/290878
Research Article

CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation

1Centre de Transplantation Hépatique, Pôle Digestif, APHP, Hôpital Saint Antoine, 184 Rue de Faubourg Saint Antoine, 75012 Paris, France
2UPMC Université Paris 6, Inserm, UMR_S938, Centre de Recherche Saint Antoine, 75012 Paris, France
3UMR 8161, Institut de Biologie de Lille, 1 Rue du Professeur Calmette, 59028 Lille, France
4Unité de Biostatistique, Hôpital Cochin, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France

Received 30 April 2013; Revised 8 October 2013; Accepted 14 October 2013; Published 19 January 2014

Academic Editor: Kenichi Harada

Copyright © 2014 Stenard Fabien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Negro and A. Hadengue, “Therapy of chronic hepatitis B,” Revue Medicale Suisse, vol. 2, no. 77, pp. 1981–1985, 2006. View at Scopus
  2. S. M. Kamal, C. S. Graham, Q. He et al., “Kinetics of intrahepatic hepatitis C virus (HCV)—specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis,” Journal of Infectious Diseases, vol. 189, no. 7, pp. 1140–1150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. P. Curry, “Hepatitis B and hepatitis C viruses in liver transplantation,” Transplantation, vol. 78, no. 7, pp. 955–963, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Velidedeoglu, K. C. Mange, A. Frank et al., “Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV- recipients,” Transplantation, vol. 77, no. 12, pp. 1834–1842, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Berenguer, M. Prieto, F. San Juan, et al., “Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients,” Hepatology, vol. 36, article 202, 2002.
  6. R. Thimme, D. Oldach, K. Chang, C. Steiger, S. C. Ray, and F. V. Chisari, “Determinants of viral clearance and persistence during acute hepatitis C virus infection,” Journal of Experimental Medicine, vol. 194, no. 10, pp. 1395–1406, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. T. Gerlach, H. M. Diepolder, M.-C. Jung et al., “Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C,” Gastroenterology, vol. 117, no. 4, pp. 933–941, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Tsai, Y. Liaw, M. Chen, C. Huang, and G. C. Kuo, “Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity,” Hepatology, vol. 25, no. 2, pp. 449–458, 1997. View at Scopus
  9. M. Murata, S. Nabeshima, N. Maeda, H. Nakashima, S. Kashiwagi, and J. Hayashi, “Increased frequency of IFN-γ-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C,” Journal of Medical Virology, vol. 67, no. 2, pp. 162–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. A. O'Garra and P. Vieira, “Regulatory T cells and mechanisms of immune system control,” Nature Medicine, vol. 10, no. 8, pp. 801–805, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Sakaguchi, N. Sakaguchi, J. Shimizu et al., “Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance,” Immunological Reviews, vol. 182, pp. 18–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, “Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases,” Journal of Immunology, vol. 155, no. 3, pp. 1151–1164, 1995. View at Scopus
  13. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, “Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance,” Nature Immunology, vol. 3, no. 2, pp. 135–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Birebent, R. Lorho, H. Lechartier et al., “Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression,” European Journal of Immunology, vol. 34, no. 12, pp. 3485–3496, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. E. Morgan, J. H. M. van Bilsen, A. M. Bakker et al., “Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans,” Human Immunology, vol. 66, no. 1, pp. 13–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Groux, A. O'Garra, M. Bigler et al., “A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis,” Nature, vol. 389, no. 6652, pp. 737–742, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Rahmoun, A. Foussat, H. Groux, J. Pène, H. Yssel, and P. Chanez, “Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity,” International Archives of Allergy and Immunology, vol. 140, no. 2, pp. 139–149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. H. L. Weiner, “Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells,” Immunological Reviews, vol. 182, pp. 207–214, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Cabrera, Z. Tu, Y. Xu et al., “An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection,” Hepatology, vol. 40, no. 5, pp. 1062–1071, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. M. Rushbrook, S. M. Ward, E. Unitt et al., “Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection,” Journal of Virology, vol. 79, no. 12, pp. 7852–7859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Boettler, H. C. Spangenberg, C. Neumann-Haefelin et al., “T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection,” Journal of Virology, vol. 79, no. 12, pp. 7860–7867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. J. MacDonald, M. Duffy, M. T. Brady et al., “CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons,” Journal of Infectious Diseases, vol. 185, no. 6, pp. 720–727, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. M. M. Velásquez-Lopera, V. L. Eaton, N. M. Lerret et al., “Induction of transplantation tolerance by allogeneic donor-derived CD4+CD25+Foxp3+ regulatory T cells,” Transplant Immunology, vol. 19, no. 2, pp. 127–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. O. Joffre, T. Santolaria, D. Calise et al., “Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes,” Nature Medicine, vol. 14, no. 1, pp. 88–92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Zeiser, V. H. Nguyen, A. Beilhack et al., “Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production,” Blood, vol. 108, no. 1, pp. 390–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Demirkiran, A. Kok, J. Kwekkeboom et al., “Low circulating regulatory T-cell levels after acute rejection in liver transplantation,” Liver Transplantation, vol. 12, no. 2, pp. 277–284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Stenard, C. Nguyen, K. Cox et al., “Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients,” Pediatric Transplantation, vol. 13, no. 1, pp. 70–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Carpentier, F. Conti, F. Stenard et al., “Increased expression of regulatory tr1 cells in recurrent hepatitis C after liver transplantation,” American Journal of Transplantation, vol. 9, no. 9, pp. 2102–2112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Calmus, C. Duvoux, G. Pageaux, et al., “Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNalpha-2a plus ribavirin,” Journal of Hepatology, vol. 57, p. 564, 2012.
  31. A. Carpentier, F. Conti, M. Carrière et al., “Analysis of gene transcription in sera during chronic hepatitis C infection,” Journal of Medical Virology, vol. 81, no. 3, pp. 473–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Zhou, S. Bailey-Bucktrout, L. T. Jeker, and J. A. Bluestone, “Plasticity of CD4+ FoxP3+ T cells,” Current Opinion in Immunology, vol. 21, no. 3, pp. 281–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. H. Banham, “Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+ regulatory T cells,” Trends in Immunology, vol. 27, no. 12, pp. 541–544, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Charbonnier, L. M. Van Duivenvoorde, F. Apparailly et al., “Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells,” Journal of Immunology, vol. 177, no. 6, pp. 3806–3813, 2006. View at Scopus
  35. R. J. Firpi, M. F. Abdelmalek, C. Soldevila-Pico et al., “One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection,” Liver Transplantation, vol. 10, no. 10, pp. 1240–1247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Akiyama, T. Ichikawa, H. Miyaaki et al., “Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C,” Intervirology, vol. 53, no. 3, pp. 154–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Feray, L. Caccamo, G. J. M. Alexander et al., “European collaborative study on factors influencing outcome after liver transplantation for hepatitis C,” Gastroenterology, vol. 117, no. 3, pp. 619–625, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. L. M. Forman, J. D. Lewis, J. A. Berlin, H. I. Feldman, and M. R. Lucey, “The association between hepatitis C infection and survival after orthotopic liver transplantation,” Gastroenterology, vol. 122, no. 4, pp. 889–896, 2002. View at Scopus
  39. J. Dumortier, J. Scoazec, P. Chevallier, and O. Boillot, “Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination,” Journal of Hepatology, vol. 40, no. 4, pp. 669–674, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Rodriguez-Luna, A. Khatib, P. Sharma et al., “Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon α2b and ribavirin: an open-label series,” Transplantation, vol. 77, no. 2, pp. 190–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Manigold and V. Racanelli, “T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies,” The Lancet Infectious Diseases, vol. 7, no. 12, pp. 804–813, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Smyk-Pearson, L. Golden-Mason, J. Klarquist et al., “Functional suppression by FoxP3+CD4+CD25 high regulatory T cells during acute hepatitis C virus infection,” Journal of Infectious Diseases, vol. 197, no. 1, pp. 46–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Charbonnier, W. G. H. Han, J. Quentin et al., “Adoptive transfer of IL-10-secreting CD4+CD49b+ regulatory T cells suppresses ongoing arthritis,” Journal of Autoimmunity, vol. 34, no. 4, pp. 390–399, 2009. View at Scopus